193 related articles for article (PubMed ID: 30670148)
1. Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition.
Xu L; Fu M; Chen D; Han W; Ostrowski MC; Grossfeld P; Gao P; Ye M
BMB Rep; 2019 Oct; 52(10):595-600. PubMed ID: 30670148
[TBL] [Abstract][Full Text] [Related]
2. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
3. Suppression of ADAM8 attenuates angiotensin II-induced cardiac fibrosis and endothelial-mesenchymal transition via inhibiting TGF-β1/Smad2/Smad3 pathways.
Yao L; Shao W; Chen Y; Wang S; Huang D
Exp Anim; 2022 Feb; 71(1):90-99. PubMed ID: 34615811
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
Sun X; Sun Y; Jiang P; Qi G; Chen X
Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
[TBL] [Abstract][Full Text] [Related]
6. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
7. Blockage of AKAP12 accelerates angiotensin II (Ang II)-induced cardiac injury in mice by regulating the transforming growth factor β1 (TGF-β1) pathway.
Li Y; Yu QH; Chu Y; Wu WM; Song JX; Zhu XB; Wang Q
Biochem Biophys Res Commun; 2018 May; 499(2):128-135. PubMed ID: 29501491
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
Sharma V; Dogra N; Saikia UN; Khullar M
Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
[TBL] [Abstract][Full Text] [Related]
9. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
10. Ets-1 upregulation mediates angiotensin II-related cardiac fibrosis.
Hao G; Han Z; Meng Z; Wei J; Gao D; Zhang H; Wang N
Int J Clin Exp Pathol; 2015; 8(9):10216-27. PubMed ID: 26617730
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition.
Liu ZH; Zhang Y; Wang X; Fan XF; Zhang Y; Li X; Gong YS; Han LP
Biomed Pharmacother; 2019 Oct; 118():109227. PubMed ID: 31351433
[TBL] [Abstract][Full Text] [Related]
14. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling.
Zhan Y; Brown C; Maynard E; Anshelevich A; Ni W; Ho IC; Oettgen P
J Clin Invest; 2005 Sep; 115(9):2508-16. PubMed ID: 16138193
[TBL] [Abstract][Full Text] [Related]
15. Schizandrin B attenuates angiotensin II induced endothelial to mesenchymal transition in vascular endothelium by suppressing NF-κB activation.
You S; Qian J; Wu G; Qian Y; Wang Z; Chen T; Wang J; Huang W; Liang G
Phytomedicine; 2019 Sep; 62():152955. PubMed ID: 31146168
[TBL] [Abstract][Full Text] [Related]
16. MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2/3-Snail signalling pathway.
Wang B; Ge Z; Wu Y; Zha Y; Zhang X; Yan Y; Xie Y
J Cell Mol Med; 2020 Nov; 24(21):12799-12812. PubMed ID: 32945126
[TBL] [Abstract][Full Text] [Related]
17. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter.
Song S; Zhang R; Cao W; Fang G; Yu Y; Wan Y; Wang C; Li Y; Wang Q
J Cell Physiol; 2019 Jun; 234(6):9052-9064. PubMed ID: 30378114
[TBL] [Abstract][Full Text] [Related]
18. Dual roles of chromatin remodeling protein BRG1 in angiotensin II-induced endothelial-mesenchymal transition.
Li Z; Kong X; Zhang Y; Zhang Y; Yu L; Guo J; Xu Y
Cell Death Dis; 2020 Jul; 11(7):549. PubMed ID: 32683412
[TBL] [Abstract][Full Text] [Related]
19. Ets-1 targeted by microrna-221 regulates angiotensin II-induced renal fibroblast activation and fibrosis.
Di J; Jiang L; Zhou Y; Cao H; Fang L; Wen P; Li X; Dai C; Yang J
Cell Physiol Biochem; 2014; 34(4):1063-74. PubMed ID: 25228106
[TBL] [Abstract][Full Text] [Related]
20. Insulin-Like Growth Factor 1 Receptor Deficiency Alleviates Angiotensin II-Induced Cardiac Fibrosis Through the Protein Kinase B/Extracellular Signal-Regulated Kinase/Nuclear Factor-κB Pathway.
Zhu J; Li Q; Sun Y; Zhang S; Pan R; Xie Y; Chen J; Shi L; Chen Y; Sun Z; Zhang L
J Am Heart Assoc; 2023 Sep; 12(18):e029631. PubMed ID: 37721135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
